InvestorsHub Logo
Followers 33
Posts 1924
Boards Moderated 1
Alias Born 08/02/2019

Re: PJ007 post# 400760

Wednesday, 12/06/2023 3:01:28 PM

Wednesday, December 06, 2023 3:01:28 PM

Post# of 403150
I am not unhappy to be divorce from Alfasigma. They start only 1 EU clinical trial in 2022 and 0 in 2023. They buy 2 different company and 1 other drug since 2022. They maybe do not have much money for a new clinical trial for a Brilacidin Ulcerative Proctitis malady with limited market. They also had first refusal privilege for other Brilacidin potentials. Ipix now is free to find an other better partner for the things Brilacidin can help in gastroenterology.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent IPIX News